Clinical Trials Browser

Phase 1/2 × Nasopharyngeal Carcinoma × Adjuvants, Pharmaceutic × Clear all

NCT05341193 2022-04-22

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 1/2 Unknown

Nasopharyngeal Carcinoma